A Study of Toripalimab Combined With Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma.

NCT04084158 · clinicaltrials.gov ↗

PHASE2

Phase

SUSPENDED

Status

100

Enrollment

OTHER

Sponsor class

Stopped combination arm delevelped significant poor prognosis

Conditions

Esophageal Squamous Cell Carcinoma

Interventions

DRUG: Toripalimab injection (JS001)
DRUG: Paclitaxel, Albumin-Bound
RADIATION: Radiotherapy
DRUG: Platinum-Based Drug

Sponsor

Zhejiang Cancer Hospital

Collaborators

[object Object]